Discovery of ZN-c3, a Highly Potent and Selective Wee1 Inhibitor Undergoing Evaluation in Clinical T
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- DOE - Office Of Science; INDUSTRY
- OSTI ID:
- 1834904
- Journal Information:
- J. Med. Chem., Vol. 64, Issue (17)
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Discovery of ZN-c3, a Highly Potent and Selective Wee1 Inhibitor Undergoing Evaluation in Clinical T
Discovery of Cyclic Acylguanidines as Highly Potent and Selective β-Site Amyloid Cleaving Enzyme (BACE) Inhibitors: Part I–Inhibitor Design and Validation
Discovery of Cyclic Acylguanidines as Highly Potent and Selective β-Site Amyloid Cleaving Enzyme (BACE) Inhibitors: Part I-Inhibitor Design and Validation
Journal Article
·
2021
· J. Med. Chem.
·
OSTI ID:1832557
+8 more
Discovery of Cyclic Acylguanidines as Highly Potent and Selective β-Site Amyloid Cleaving Enzyme (BACE) Inhibitors: Part I–Inhibitor Design and Validation
Journal Article
·
2013
· Journal of Medicinal Chemistry
·
OSTI ID:1107404
+18 more
Discovery of Cyclic Acylguanidines as Highly Potent and Selective β-Site Amyloid Cleaving Enzyme (BACE) Inhibitors: Part I-Inhibitor Design and Validation
Journal Article
·
2010
· Journal of Medicinal Chemistry
·
OSTI ID:1002632
+18 more